a.ramos
Submits third-party assay reports on material purchased directly. Based in Kaunas.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.05%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043478 | CJC-1295 with DAC | BCH | BCH-2607-H5235 | PeptideMeter | 2026-Q3 | 97.63 | 5.42 | 90.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043555 | Cagrilintide | SIG | SIG-2603-6212 | Janoshik | 2026-Q2 | 98.69 | 4.94 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042270 | Semaglutide | TFC | TFC-2602-H9925 | PeptideMeter | 2026-Q1 | 99.22 | 1.29 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019479 | GHRP-2 | JEEP | JEEP-2508-S8448 | Janoshik | 2025-Q4 | 99.88 | 3.00 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019354 | Semaglutide | HYB | HYB-2510-H6122 | Janoshik | 2025-Q4 | 99.28 | 4.69 | 88.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019131 | AOD-9604 | GSP | GSP-2505-S3921 | VendorInvestigate | 2025-Q4 | 98.70 | 2.96 | 103.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020659 | Tirzepatide | SGN | SGN-2506-J8349 | VendorInvestigate | 2025-Q3 | 96.49 | 2.06 | 92.3 | Buyer-sourced | 0 | FAIL |
| AX-2025-020975 | PT-141 (Bremelanotide) | WXT | WXT-2507-R4042 | Janoshik | 2025-Q3 | 98.88 | 4.76 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019386 | Tirzepatide | HYB | HYB-2507-A6586 | Janoshik | 2025-Q3 | 99.67 | 4.26 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019500 | Tirzepatide | JEEP | JEEP-2412-U8403 | Medutest | 2025-Q2 | 99.42 | 2.43 | 89.7 | Buyer-sourced | 1 | MARGINAL |